 |
|
|
|
|
|
 |
 |
 |
 |
 |
 |
|
||||||||||||||||||||
Title: |
Management of Gestational Trophoblastic Neoplasia with 5-Fluorouracil and Actinomycin D in Northern China | |||||||||||||||||||
| Authors: | Ying Zhao, M.D., Weiyuan Zhang, M.D., and Wei Duan, M.D. | |||||||||||||||||||
|
OBJECTIVE: To study risk factors associated with the number of chemotherapy courses required to obtain normal b-human chorionic gonadotropin (b-hCG) levels and evaluate the effectiveness of combination chemotherapy using 5-fluorouracil (5-FU) and actinomycin D (Act D) (FA) for gestational trophoblastic neoplasia (GTN).
STUDY DESIGN: A retrospective study of GTN cases from January 1995 to July 2007 at the Beijing Obstetrics and Gynecology Hospital was performed. RESULTS: During the study period, 240 cases of GTN were diagnosed and managed at our institution. A stepwise regression analysis revealed that the interval between evacuation and chemotherapy, parity, age and b-hCG level were associated with number of chemotherapy courses required to obtain normal b-hCG levels. In addition to 4 patients with placental site trophoblastic tumor, FA was used in 218 patients (136 low risk and 82 high risk). CONCLUSION: Early detection of GTN and timely administration of chemotherapy decreases the number of chemotherapy courses required. The combination chemotherapy of 5-FU and Act D is effective in low- and high-risk patients with GTN, but not in patients with placental site trophoblastic tumor; it can be used as primary chemotherapy regimen in high-risk patients with GTN, except those with extensive metastases. (J Reprod Med 2009;54:88-94) |
||||||||||||||||||||
| Keywords: | actinomycin D, 5-fluorouracil, gestational trophoblastic neoplasia, mole | |||||||||||||||||||
| Acrobat Reader 7.0 is recommended to properly view and print the article.
Reader can be downloaded from  |
||||||||||||||||||||
